Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Phase II trial with bleomycin, CCNU, and streptozotocin in patients with metastatic cancer of the breast.

Band PR, Canellos GP, Sears M, Israel L, Pocock SJ. Phase II trial with bleomycin, CCNU, and streptozotocin in patients with metastatic cancer of the breast. Cancer Treat Rep. 1977 Oct; 61(7):1365-7.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.